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Vaccinia cores inhibit translation in cell-free protein synthesis systems at two stages: initiation; and, as 
shown here, elongation. The former effect tends to obscure the latter. Elongation control could, however, 
be revealed as follows: when, in a reticulocyte of L-cell lysate, initiation was blocked by a drug (edein), 
the residual [3sS]methionine incorporation, was severely reduced by the subsequent addition of vaccinia 
cores. The elongation block could also be demonstrated by analysis of ribosome profiles: treatment with 
edein alone permitted ribosomal run-off; treatment with either the elongation inhibition anisomycin or 
with cores preserved the polyribosomes. 
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1. INTRODUCTION 
The mechanism by which vaccinia virus inhibits 
protein synthesis in vivo is largely unknown. 
Several authors have observed the shut-off of host 
protein synthesis in the absence of viral RNA and 
protein synthesis [l-3] which suggests that a com- 
ponent of the virion is involved. Further work has 
shown that the addition of vaccinia cores to cell- 
free systems results in the inhibition of protein 
synthesis [4,5]. 
followed by centrifugation at 20000 rev./min for 
45 min in an SW 50 rotor. The cores were resus- 
pended in 10 mM Tris buffer (pH 7.5) and recen- 
trifuged to remove traces of NP-40. The final 
pellet was dissolved in 10 mM Tris buffer (pH 7.5) 
to give 10” core particles/ml. 
2.2. Cell-free systems 
Evidence has been obtained that inhibition by 
vaccinia cores occurs at the initiation step ‘of pro- 
tein synthesis [4-71. Here, we present evidence that 
vaccinia cores can also affect the elongation step of 
protein synthesis. 
2. MATERIALS AND METHODS 
The rabbit reticulocyte lysate was prepared and 
treated with micrococcal nuclease as in [9, lo]. The 
reaction mixture for studying endogenous protein 
synthesis in reticulocyte lysates was as in [9] with 
the following modifications: unlabeled amino 
acids were added at 200 PM each, [%]methionine 
at 5 &i/incubation mixture, glucose and 2-amino- 
purine at 2 and 6 mM, respectively. Protein syn- 
thesis was assayed by determining the incorpora- 
tion of [35S]methionine into protein as in [4]. 
2.2. Preparation of vaccinia cores 
The WR strain of vaccinia virus was propagated 
in L929 cells and purified as in [B]. Cores were pre- 
pared by dissolving purified virus in 25 mM Tris 
buffer (PH 7.5) containing 0.25% Nonidet P40 
(NP-40) and 50 mM 2-mercaptoethanol (2-ME) 
An S 30 from L-cells was prepared as follows: 
cells were washed 3 times and resuspended in 2 vol. 
buffer (10 mM Tris-HCl (pH 7.5), 1.5 mM 
MgClz, 15 mM KC1 and 5 mM 2-ME), left on ice 
for 10 min and then broken by 20 strokes in a tight 
fitting Dounce homogenizer. The lysate was made 
isotonic by addition of buffer A containing 
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200 mM Hepes (pH 7.5),800 mM KC1 and 30 mM 
MgCL. The S 30 was obtained by centrifugation 
for 10 min at 10000 rev./min and chromato- 
graphed over Sephadex G-25 coarse equilibrated 
with buffer A (1: 10 diluted and containing 5 mM 
2-ME). The peak of the void volume fraction was 
collected and frozen in liquid nitrogen. The condi- 
tions for protein synthesis in the L-cell lysate were 
as in [lo]. 
2.3. Materials 
Micrococcal nuclease was obtained from PL 
Biochemicals, NP-40 from Fluka, edeine from 
Calbiochem and anisomycin from Sigma. 
3. RESULTS 
3.1. Effect of vaccinia cores on in vitro protein 
synthesis in the presence of edeine 
The study of the effect of vaccinia cores on 
elongation requires a cell-free system that incor- 
porated [35S]methionine into protein in the presence 
of an inhibitor of initiation. 
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Fig. 1. Effect of vaccinia cores on endogenous protein 
synthesis in a cell-free system from L929 cells: (M) no 
addition; (M) 1 pM edeine; (0-0) 2 or 5 ,uM 
edeine; (H) 1.6 x 10” vaccinia cores/ml; (w) 
1.6 x 10” vaccinia cores/ml + 2 ,zM edeine. 
After the addition of edeine to our L929 cell- 
lysate at a concentration that completely blocks 
initiation, [35S]methionine incorporation still con- 
tinues at 0.3 pmol.min-’ .ml-‘. Vaccinia cores 
were added to this lysate in the presence and 
absence of 2pM edeine (fig. 1). If inhibition were 
only at the level of initiation the curve of cores plus 
edeine should coincide with the 2 PM edeine curve. 
However, since the combined action of cores plus 
edeine is clearly more inhibitory than edeine alone 
it would appear that vaccinia cores affect the elon- 
gation step of protein synthesis. 
In addition we analyzed the effect of vaccinia 
cores on elongation in a micrococcal nuclease- 
treated reticulocyte lysate supplemented with en- 
cephalomyocarditis (EMC) RNA. Addition of 
5 PM edeine together with EMC RNA at the start 
of incubation blocks the incorporation of [35S]- 
methionine into protein almost completely 
(fig. 2A). To study the effect of vaccinia cores on 
elongation it was necessary to add the edeine 
15 min after the start of incubation to enable ini- 
tiation to take place and thus elongation to occur 
(fig. 2B). The combined action of cores and edeine 
was again more inhibitory than edeine alone, con- 
firming our findings with the L929 cell lysate. 
Control experiments howed that NP-40 in the 
concentrations used to disrupt cores did not affect 
the initiation or elongation step of protein synthe- 
sis in L-cell lysate. NP-40 up to 0.2% was not in- 
Timo.min Time. min 
Fig. 2. Inhibition of encephalomyocarditis (EMC) RNA 
translation in nuclease-treated reticulocyte lysate by 
vaccinia cores and edeine: ( W) no addition; (o---o) 
3 pl cores; (H) 5 pM edeine; (o----a) 3 pl cores + 
5 pM edeine. In A additions were made at zero time, in 
B additions (4) were made 15 min after the start of 
incubation. 
428 
Volume 153, number 2 FEBS LETTERS March 1983 
hibitory for reticulocyte lysate. Tris and 2-ME did 
not inhibit protein synthesis in the concentrations 
used in our experiments, 
3.2. Effect of vacciniu cores on the polyribosome 
profile of reticulocyte lysates 








Fig. 3. Effect of vaccinia cores and edeine on endo- 
genous protein synthesis and poiyribosome profile of 
reticulocyte Iysates. The inhibition of the protein synthe- 
sis by cores and edeine is shown in (A): (w) no 
addition; (Q---+) 0.4 pM edeine; (~1 1.6 x 10” 
cores/ml; (+--w) 2pM edeine. Reticulocyte lysate 
(60 pl), in 100 hl final vol. was incubated in the absence 
(B) or in the presence (C) of 1.6 x IO” cores/ml or with 
0.4 FM edeine (D). After 10 min the reaction was 
stopped with 200~1 gradient buffer (50 mM Tris-HCI 
(pH 7.5), 100 mM KCI, 5 mM Mg(AC)2 and 5 mM 
2-ME) containing 400 pg cycloheximide/ml. Samples 
were loaded onto lo-50% isokinetic sucrose gradients in 
gradient buffer (containing 75 gg cycloheximide/ml) 
and centrifuged at 36000 rev./min for 110 min in a 
Beckman SW 41 rotor. The contents of the tubes were 
monitored at 256 nm using an Isco type 6 optical unit. 
appearance of polyribosomes when initiation is the 
rats-limiting step of protein synthesis. However, 
an inhibitor of elongation should result in an in- 
crease in polysomes but only if free ribosomal 
subunits and mRNA are still available. 
Fig. 3 shows the effect of vaccinia cores and the 
initiation inhibitor edeine on the polyribosome 
profile of a reticulocyte lysate after 10 min incuba- 
tion. The addition of edeine at 0.4pM which in- 
hibited protein synthesis less than cores (fig. 3A), 
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Fig. 4. Effect of addition of extra Iysate on protein syn- 
thesis in reticulocyte lysates incubated in the presence 
and absence of mRNA and cores. Duplicate samples of 
a micrococca1 nuclease-treated reticulocyte lysate were 
incubated respectively without mRNA, with mRNA and 
with mRNA plus cores (final vol. 3Opl). After 20 min 
incubation 20 ~1 nuclease-treated Iysate (containing all 
ingredients for protein synthesis except mRNA) was 
added to one set of incubation mixtures (thereby 
doubling the volume). Samples of 5 pl were taken at in- 
tervals to measure the incorporation of [3sS]methionine 
into protein. Samples of 10~1 were taken when extra 
lysate had been added to the incubation mixture: 
(C---G) - mRNA; (o---e) - mRNA -t- 20~1 nuclease- 
treated lysate at 20 min; (v-+) + mRNA; (v---v) c 
mRNA + 20 pl nuclease-treated lysate at 20 min; 
(cc-a) + mRNA + 1.5 x IO’” core particles/ml; 
(8--- R) + mRNA c 1.5 x 10” core particles/m1 + 20 pl 
nuclease-treated lysate at 20 min. 
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caused an almost complete loss of polyribosomes 
(fig. 3D). The addition of cores, however, did not 
change the profile (fig. 3C), as was the case with 
anisomycin, an elongation inhibitor (not shown). 
From this we conclude that in this system it is 
mainly the elongation step of protein synthesis 
which is inhibited by cores. An effect on the termi- 
nation step of protein synthesis seems less likely 
because an accumulation of large polysomes was 
not found. 
The possibility that protein synthesis is inhibited 
by degradation of mRNA seems unlikely in view of 
fig. 3C. Additional evidence that mRNA is not de- 
graded by cores is presented in fig. 4. Lysates were 
incubated with vaccinia cores for 20 min at which 
time protein synthesis proceeds at a low rate. Addi- 
tion of nuclease-treated lysate (-mRNA) to this 
core-inhibited lysate at 20 min resulted in an in- 
creased rate of protein synthesis. At 60 min, an 
extra 28 000 cpm were incorporated due to the 
addition of nuclease-treated lysate. Part of this in- 
crease was caused by background incorporation 
(13 000 cpm). The difference of 15 000 cpm has to 
be ascribed to translation of the added mRNA into 
protein. This indicates that mRNA is still 
biologically active in the core-inhibited Iysate. 
4. DISCUSSION 
Here, we show that the elongation step of pro- 
tein synthesis is inhibited by vaccinia cores in two 
different cell-free systems where initiation was 
blocked by edeine. Analysis of polyribosome pro- 
files of lysates incubated in the presence and 
absence of cores confirmed that inhibition occur- 
red at the elongation step of protein synthesis 
(fig. 3). This result seems to contradict the obser- 
vation 141 that vaccinia cores fail to inhibit 
poly(Phe) synthesis under the direction of poly(U). 
At present we cannot explain this discrepancy. 
The fact that inhibition at the elongation step of 
protein synthesis was overlooked till now is prob- 
ably caused by the fact that under normal condition 
(fig. 2A) we cannot discriminate between initiation 
and elongation inhibition. 
Since vaccinia cores inhibit both the initiation 
and elongation step of protein synthesis, the possi- 
bility exists that more than one component of the 
translational machinery is affected. Furthermore, 
it would be interesting to determine whether a 
reduced rate of elongation also exists in cells 
shortly after infection with vaccinia virus. 
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